Click on image for larger view.
A 50 year old lady got her presbbyopia glasses off with the first PAP IMI treatment on her eyes some two years ago. Since then, she maintains her eyes good condition by taking a 5 minute exposure once every one or two months.
THE DEVICE WITH NUCLEAR TRANSMUTATIONAL BIOENERGY
NON - INVASIVE ELECTROINSERTION IN VIVO
IMPROVES: METABOLISM, ANABOLISM, DRUG DELIVERY,TRANSMEMBRANE ACTION, CELLULAR ACTIVITY
WORLD'S STRONGEST PULSED ELECTROMAGNETIC FIELD (PMF)
There have been numerous anecdotal reports of IMI therapy rapidly clearing bacterial infections--often coincidentally in treating other complaints. In one case, for example, a woman being treated for breast cancer experienced a spontaneous remission of a chronic bacterial infection in her mouth.
Mitosis, the initiation of cell division, is triggered in bacteria as in otner cells by the TMP dropping to a critical point, and they multiply much faster than cancer cells. We can only suppose that the same mechanisms may be involved in the bactericidal action of the IMI as with cancer cells; prevention of mitosis by elevating the TMP and/or potentiation of the immune system and increasing antibody access by electroporation through the thinned membrane.
At this time, the only evidence that IMI therapy may have some effect on certain types of virus is the fact that it has suppressed outbreaks of herpes within hours after a 20minute treatment, rather than the days usually required for such outbreaks to subside.
An unexpected effect of IMI treatments is their remarkably fast ability to relieve pain from nearly any source. At least in part, this may be due to the increase in blood circulation in the affected area. For a more detailed analysis of this phenomenon, one must explore the MelzakWall theory of pain suppression which is beyond the immediate scope of this paper.
However, anyone who has ever used the simple little Transdermal Electrical Nerve Stimulation (TENS) system of pain control can appreciate the effectiveness of the weak pulses of electricity these pocket-sized devices send through the skin to a small affected area.
Well over 90% of musculoskeletal pain, pain from tissue trauma, cancer, adhesions, rheumatism, burns, inflammation. etc. is significantly or totally relieved by IMI therapy, often permanently, although chronic pain of long standing may require a regimen of treatments over several days or weeks.
IMI therapy has proven so effective in treating the symptoms of full-blown AIDS in isolated cases that at least two large-scale clinical studies are being developed to document these effects on a scientific basis. In one of the first such cases, being given IMI treatments for Kaposi's sarcoma and pneumocVstIs Carlinil, it was noted that his T-cell count increasea with each treatment, as shown in the chart below.
ML was moribund when first seen. We believe these results would have been obtained faster if IVIL had not skipped so many treatment appointments because, as he said, "I felt so good."
Subsequently, many other patients debilitated by AIDS symptoms began to come in to clinics where experimental IMI trials were being conducted. Without exception, these patients experienced disappearance of AIDSrelated opportunistic infections, and the very significant potentiation of their immune systems.
It is emphasized that IMI therapy is not a cure for HIV infection, but continued periodic treatments (weekly or biweekly in most cases) has enabled these cases to maintain a healthy condition and to pursue their normal, productive life style.
As yet, we have no explanation to offer of the mechanism by which IMI treatments have just been reported to eliminate tapeworm and hookworm infestations.
Although no specific claims can be made for IMI therapy pending the results of statistically significant clinical studies, it is noted that in over six years of experimental use in Europe and North America, a surprising number of anecdotal reports have been received from physicians on the efficacy of IMI therapy in a broad spectrum of applications. In many cases, these reports have been reconfirmed by independent medical experts, and the statements of the patients themselves.
It is emphasized, however, that although over 80% of these varied anecdotal reports have indicated successful results from IMI treatment, the balance have indicated only partial results and a few failures (usually due to premature termination of treatment protocols). An exception is chronic and acute pain syndromes, for which the success rate appears to be in the. high ninety percentiles.
Moreover, there has not been time or adequate cohorts to develop optimum posology, or treatment protocols for all the complaints listed in the following Applications Summary, and it does not seem likely that extended clinical trials will be conducted for such lesser complaints as hemorrhoids, such transient complaints as dysentery, or conditions that readily yield to pharmacological or surgical treatment.
Nevertheless, the broad spectrum of complaints that do appear to be relieved by IMI therapy is impressive, and appears to support the general theory that enhancing cell membrane potential, thereby increasing cell energy, may have the apparently paradoxical effect of enhancing the health of normal cells while depriving cancer cells of their reproductive power by inhibiting mitosis, and thus initiating oncolysis by aging and/or starvation.
Also, particularly in cancer treatment, the importance of IMI's electroporation effects as an adjunct to chemotherapy must not be overlooked.
APPLICATIONS SUMMARY
Addison's disease
Adhesions
AIDS
Allergy
Amoebic dysentery
Asbestosis
Asthma
Ankylosis
Arthritis
Bacterial infections
Burns and burn pain
Cancer, malignant
Carpal tunnel
COPD
Cramps, abdominal
Cramps, muscular
Crvptococcosis
Dysmenorrhea
Dyspareunia
Emphysema
Fractures
Fungal infections
Hematoma
Hemorrhoids
Hemostasis
Herpes
HVperesthesia
Keloids
Ovarian cysts
Pain, acute
Pain, chronic
Pain, phantom limb
Pneumonia
Sciatica
ScIeroiderma
Silicosis
Tendinitis
Trauma healing
Tumors, benign
Warts